<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have treated 28 patients (pts) with malignant <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> with allogeneic bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="1" pm="."><plain>18 pts had <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic (ALL) and non lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL), 5 <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 2 severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA), 1 myelodisplasia, 1 Fanconi's <z:hpo ids='HP_0001903'>anemia</z:hpo> and 1 advanced Non Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> but three received the graft from HLA identical sibling donors </plain></SENT>
<SENT sid="3" pm="."><plain>We used conditioning with total body irradiation and chemotherapy (<z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28680">cytarabine</z:chebi> and <z:chebi fb="0" ids="4911">etoposide</z:chebi>) in 17 pts and chemotherapy alone in 11 </plain></SENT>
<SENT sid="4" pm="."><plain>24 pts had full hematological recovery 18 to 25 days post BMT </plain></SENT>
<SENT sid="5" pm="."><plain>15 pts died after BMT as a consequence of toxicity or early <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (4), graft failure (2), <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> (4) or relapse (5) </plain></SENT>
<SENT sid="6" pm="."><plain>Actuarial event free survival for the group with favorable prognosis (SAA, ALL and ANLL in first or second remission and <z:mp ids='MP_0005481'>CML</z:mp> in <z:hpo ids='HP_0011010'>chronic</z:hpo> phase) is 57% at 36 months </plain></SENT>
<SENT sid="7" pm="."><plain>Allogeneic BMT is an effective and feasible therapeutic procedure for selected patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
</text></document>